A paper can contain human measurements without being a human trial of an administered peptide. This distinction is essential when reading the exercise component of the 2021 MOTS-c report. Primary publication
The human component
Ten healthy young men participated in an exercise investigation involving stationary cycling and collection of blood and skeletal-muscle samples. The authors examined endogenous MOTS-c responses around exercise. This human component was not an intervention testing administered MOTS-c in people. The publication also contains nonhuman experimental work, which must retain its separate model labels. Primary publication
Our appraisal: separate cause, response, and intervention
Observing that a biological measurement changes around exercise is a different proposition from demonstrating that administering the measured substance reproduces the benefits of exercise. The first observation can support further investigation without establishing the second claim.
Consider an invented example in which exercise changes marker X and performance also changes. The observations alone do not establish that giving X would cause the performance change. X could be a mediator, a consequence, or a correlated response. Distinguishing these possibilities requires additional experiments and appropriate controls.
A useful extraction worksheet
For each part of a mixed-model paper, record the organism or sample, whether a substance was administered, the comparator, and the actual endpoint. Then record what was measured rather than replacing all outcomes with a general term such as “rejuvenation.”
In this case, our full-paper review should keep the human sampling schedule and assays apart from any animal intervention schedule. It should also inspect assay specificity, within-person changes, eligibility criteria, and uncertainty around the small human sample. These are review questions, not a claim that a particular assay is invalid.
The page's narrow contribution is to prevent a model-switching error: evidence from one experimental component must not acquire a different species or intervention merely because it appears in the same publication.
Frequently asked questions
Were human participants involved?
Yes, in the exercise and sampling component.
Does that make the paper a human MOTS-c treatment trial?
No. Human involvement and human peptide administration are different facts.
Were the human participants broadly representative of everyone?
The reported exercise sample was a small selected group of young men.
Does measuring a natural peptide validate an external product?
No. It does not establish a separate product's identity or effects.
Can animal intervention findings be relabeled as human results?
No. Species and design labels must remain attached.
Does a response to exercise prove an exercise replacement?
No. That is a different and much broader claim.
What did this appraisal inspect?
The primary publication's indexed human methods and sampling descriptions. A full cross-model methods audit remains pending before release.